Steris Q2 adjusted EPS beats; fiscal 2027 outlook lifted
Steris Q2 adjusted EPS beats; fiscal 2027 outlook lifted
Overview
The infection prevention firm's fiscal Q2 revenue rose 9% yr/yr, with 8% organic growth
Adjusted EPS for fiscal Q2 rose and beat analyst expectations
Company raised fiscal 2027 adjusted EPS outlook, citing solid performance and tariff refunds
Outlook
Company expects fiscal 2027 revenue growth of 7-8% as reported, 6-7% organic
STERIS raises fiscal 2027 adjusted EPS outlook to $11.35-$11.55 from $11.10-$11.30
Result Drivers
LIFE SCIENCES GROWTH - Co said Life Sciences segment revenue rose 18%, led by 53% growth in capital equipment and higher consumables and service revenue
TARIFF REFUNDS - Co said tariff refunds provided a $20 mln pre-tax benefit to quarterly results
Company press release: ID:nGNE4TmQnv
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Adjusted EPS | Beat | $2.94 | $2.68 (7 Analysts) |
Q2 EPS |
| $2.19 |
|
Q2 Adjusted Net Income | Beat | $286.80 mln | $262.41 mln (6 Analysts) |
Q2 Net Income |
| $213.70 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for STERIS plc is $269.50, about 16.5% above its November 3 closing price of $231.35
Reuters Recommended Reads
Nov 4 - UK's Smith & Nephew misses Q3 revenue estimates, cuts outlook on slower US orthopaedics market
Nov 4 - LivaNova Q3 revenue beats estimates on cardiopulmonary segment strength
Nov 4 - Zimmer Biomet Q3 sales beat estimates, raises FY outlook
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)